|
|
|
Is enzymatic ligation a futuristic dream or a current commercial reality? In this segment, industry experts Claire McCleod and Jill Caswell explore how the sector has moved past the proof-of-concept stage into early commercialization and what this looks like/means for early adopters today. |
|
|
|
|
|
|
| Expand Your Toolbox For Quality mRNA Manufacturing | White Paper | Roche CustomBiotech | Explore guidelines for the use of SP6 RNA Polymerase in mRNA synthesis and your mRNA production processes, as well as guidelines you can use to determine if SP6 RNA Polymerase is a good alternative. |
|
|
|
|
|
| Purification And QC Of An RNA 21‑Mer Oligonucleotide Via LC‑MS | Poster | By Justin Townsend, Linda Hagman, Filip Bergqvist, et al., Cytiva | See how buffer choice, gradient strategy, and pretreatment steps influence recovery, purity, and resolution when purifying a native RNA oligo, with analytical confirmation and practical guidance. |
|
|
|
|
|
|